Previous studies are consistent with our data, in which clinical assays have shown changes in the balance of pro- and anti-inflammatory cytokines in patients with MDD without pharmacological treatment [21] and lower IFN-γ and IL-2 levels [52]. This evidence concerns the gene IFNG and major depressive disorder.